Molndal, Sweden

Nils A Svensson

This inventor holds 2 USPTO granted patents. Top assignees: Nobel Chemicals Ab, The Upjohn Co.. Active years: 1989-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1989-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nils A Svensson: Innovator in Pharmaceutical Chemistry

Introduction

Nils A Svensson is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that are therapeutically useful for treating central nervous system disorders. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

One of Nils A Svensson's latest patents is focused on "Halo substituted aminotetralins." This invention involves therapeutically useful tetralins and pharmaceutically acceptable acid addition salts. The compounds are designed to treat various central nervous system disorders. Another significant patent is for a "Method of preparing substituted cyclic carboxylic acids." This method outlines a process for oxidizing a corresponding substituted cyclic hydrocarbon under alkaline conditions, using specific catalysts, which can be performed at room temperature and atmospheric pressure.

Career Highlights

Throughout his career, Nils A Svensson has worked with reputable companies such as Nobel Chemicals AB and The Upjohn Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Nils A Svensson has collaborated with notable colleagues, including Nils P Stjernlof and Hakan V Wikstrom. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Nils A Svensson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for central nervous system disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…